BALYASNY ASSET MANAGEMENT L.P. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,059,160
+136.4%
168,388
+306.0%
0.00%
+200.0%
Q3 2022$448,000
-87.1%
41,479
-57.8%
0.00%
-94.1%
Q1 2021$3,467,000
-37.5%
98,208
-33.2%
0.02%
-58.5%
Q3 2020$5,546,000147,0590.04%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders